813.654943
[Ãëàâíàÿ/Ïîèñê] [Ïðîèçâîäèòåëè] [Ìîñêâà] [Ñ-Ïá] [Äðóãèå] [Îáùèé] [Çàÿâêè] [Âûáîðêà]

Öåíû íà ÒÀÁÅÊÑ ÒÀÁË. Õ100 - ÒÛÊÂÅÎË ÔË. 100 ÌË. Õ1

Ïðîäàâåö: ÏÓËÜÑ (Ñàíêò-Ïåòåðáóðã, (812) 108-21-58(-59), 108-20-18(-22), 103-44-38(-39))

Ïîêàçàòü âñå ïîçèöèè ïðàéñ-ëèñòà
Ïåðåéòè ê ñòðàíèöå: 1 ... 79 80 81 82 83 84 85 86 87 88 89 ... 105
Ïåðåéòè ê íàèìåíîâàíèþ: [0-9] [A-Z] À Á Â Ã Ä Æ Ç È É Ê Ë Ì Í Î Ï Ð Ñ Ò Ó Ô Õ Ö × Ø Ý Þ ß
ÍàèìåíîâàíèåÏðîèçâîäèòåëüÖåíà $Öåíà ðóá
ÒÀÁÅÊÑ ÒÀÁË. Õ100SOPHARMA276.22
ÒÀÁËÅÒÊÈ ÎÒ ÊÀØËß Õ10ÒÀÒÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ1.17
ÒÀÂÀÍÈÊ Ð-Ð 0.5 % ÔË. 100 ÌË. Õ1AVENTIS PHARMA DEUTSCHLAN1764.36
ÒÀÂÀÍÈÊ ÒÀÁË. 250 ÌÃ Õ5AVENTIS PHARMA DEUTSCHLAN694.33
ÒÀÂÅÃÈË Ð-Ð Â/Â È Â/Ì ÂÂÅÄÅÍ. 0.1 % ÀÌÏ. 2 ÌË. Õ5NOVARTIS/NYCOMED GMBH95
ÒÀÂÅÃÈË ÒÀÁË. 1 ÌÃ Õ20FAMAR ITALY S.P.A.87.56
ÒÀÊÒÈÂÈÍ Ð-Ð 0.01 % ÀÌÏ. 1 ÌË. Õ5ÁÈÎÌÅÄ ÈÌ. ÌÅ×ÍÈÊÎÂÀ330.77
ÒÀÌÎÊÑÈÔÅÍ ÒÀÁË. 10 ÌÃ Õ30ÑÅÂÅÐÍÀß ÇÂÅÇÄÀ ÇÀÎ16.85
ÒÀÍÀÊÀÍ ÊÀÏËÈ 4 % 30 ÌË. Õ1BEAUFOUR IPSEN530.52
ÒÀÍÒÓÌ ÂÅÐÄÅ ÔË. 120 ÌË. Õ1ANGELINI FRANSESCO160.75
ÒÀÍÒÓÌ ÐÎÇÀ Ð-Ð ÂÀÃÈÍ. 0.1 % ÔË. 140 ÌË. (Ñ ÊÀÍÞËÅANGELINI FRANSESCO495.48
ÒÀÐÈÂÈÄ ÒÀÁË. 200 ÌÃ Õ10AVENTIS290.28
ÒÀÓÔÎÍ 4 % ÒÞÁ.-ÊÀÏ. 1.3 ÌË. Õ5ÌÎÑÊÎÂÑÊÈÉ ÝÍÄÎÊÐÈÍÍÛÉ ÇÀ20.07
ÒÀÓÔÎÍ 4 % ÔË./ÊÀÏ. 10 ÌË. Õ1ÑËÀÂßÍÑÊÀß ÀÏÒÅÊÀ23.5
ÒÀÓÔÎÍ 4 % ÔË./ÊÀÏ. 5 ÌË. Õ1ÌÎÑÊÎÂÑÊÈÉ ÝÍÄÎÊÐÈÍÍÛÉ ÇÀ20.37
ÒÅÉÌÓÐÎÂÀ ÏÀÑÒÀ ÒÓÁÀ ÀËÞÌ. 50 Ã. Õ1ÕÈÌÎÏÒÎÐÃ ÒÎÐÃÎÂÛÉ ÄÎÌ ÇÀ14.05
ÒÅËÔÀÑÒ ÒÀÁË. 180 ÌÃ Õ10AVENTIS PHARMA DEUTSCHLAN357.67
ÒÅËÔÀÑÒ ÒÀÁË. 30 ÌÃ Õ10AVENTIS PHARMACEUTICALS I167.4
ÒÅÌÏÀËÃÈÍ ÒÀÁË. Õ100SOPHARMA169.89
ÒÅÌÏÀÍÃÈÍÎË ÒÀÁË. Ï/Î Õ10BALKANPHARMA25.57
ÒÅÍÎÐÈÊ ÒÀÁË. 50 ÌÃ Õ28IPCA LABORATORIES LTD47.48
ÒÅÍÎÐÈÊ ÔÎÐÒÅ ÒÀÁË. 100 ÌÃ Õ28IPCA LABORATORIES LTD62.54
ÒÅÍÎÒÅÍ ÒÀÁË. Ä/ÄÅÒÅÉ Õ40ÌÀÒÅÐÈÀ-ÌÅÄÈÊÀ105.71
ÒÅÍÎÒÅÍ ÒÀÁË. Õ40ÌÀÒÅÐÈÀ-ÌÅÄÈÊÀ101.13
ÒÅÎÏÝÊ ÐÅÒÀÐÄ ÒÀÁË. 100 ÌÃ Õ50ÔÀÐÌÀÏÝÊ53.21
ÒÅÎÏÝÊ ÐÅÒÀÐÄ ÒÀÁË. 200 ÌÃ Õ50ÔÀÐÌÀÏÝÊ60.84
ÒÅÎÒÀÐÄ ÐÅÒÀÐÄ ÊÀÏÑ. 350 ÌÃ Õ40KRKA149.46
ÒÅÐÀÂÈÒ ÏÐÅÃÍÀ ÒÀÁË. Õ30SAGMEL INC154.21
ÒÅÐÀÂÈÒ ÏÐÅÃÍÀ ÒÀÁË. Õ60SAGMEL INC223.54
ÒÅÐÀÂÈÒ ÒÀÁË. Õ30SAGMEL INC124.43
ÒÅÐÀÔËÅÊÑ ÀÄÂÀÍÑ ÊÀÏÑ. Õ60SAGMEL INC504.75
ÒÅÐÀÔËÅÊÑ ÊÀÏÑ. Õ100SAGMEL INC995.38
ÒÅÐÀÔËÅÊÑ ÊÀÏÑ. Õ60SAGMEL INC639.19
ÒÅÐÀÔËÞ /ËÅÑÍÛÅ ßÃÎÄÛ/ ÏÎÐ. Ä/Ð-ÐÀ Õ10NOVARTIS/PANTEON155.57
ÒÅÐÀÔËÞ /ËÈÌÎÍ/ ÏÎÐ. Ä/Ð-ÐÀ Õ10FAMAR FRANCE/PATHEON145.96
ÒÅÐÀÔËÞ ÁÐÎ ÌÀÇÜ ÒÓÁÀ 40 Ã. Õ1NOVARTIS146.11
ÒÅÐÀÔËÞ ËÀÐ ÑÏÐÅÉ 30 ÌË.NOVARTIS138.06
ÒÅÐÀÔËÞ ËÀÐ ÒÀÁË. Ä/ÐÀÑÑÀÑ. Õ16NOVARTIS100.53
ÒÅÐÀÔËÞ ÝÊÑÒÐÀ /Ñ ßÁËÎÊÎÌ È ÊÎÐÈÖÅÉ/ ÏÎÐ. Ä/Ð-ÐÀNOVARTIS/PANTEON139.18
ÒÅÐÀÔËÞ ÝÊÑÒÐÀÒÀÁ ÒÀÁË. Ï/Î Õ10NOVARTIS113.87
ÒÅÐÁÈÍÎÊÑ ÒÀÁË. 250 ÌÃ Õ14UNIQUE PHARMACEUTICAL LAB497.86
ÒÅÐÆÈÍÀÍ ÒÀÁË. ÂÀÃ. Õ10LABORATOIRES BOUCHARA-REC302.32
ÒÅÐÆÈÍÀÍ ÒÀÁË. ÂÀÃ. Õ6LABORATOIRES BOUCHARA-REC209.73
ÒÅÐÌÈÊÎÍ ÊÐÅÌ Ä/ÍÀÐÓÆ.ÏÐÈÌ. 1 % ÒÓÁÀ 15 Ã. Õ1ÔÀÐÌÑÒÀÍÄÀÐÒ ÔÈÒÎÔÀÐÌ121.6
ÒÅÐÌÎÏÑÎË ÒÀÁË. Õ10ÔÀÐÌÑÒÀÍÄÀÐÒ ÒÎÌÑÊ1.11
ÒÅÐÏÈÍÊÎÄ ÒÀÁË. Õ10ÔÀÐÌÑÒÀÍÄÀÐÒ ËÅÊÑÐÅÄÑÒÂÀ184.01
ÒÅÑÒ 5 ÌÈÍÓÒ ÍÀ ÁÅÐÅÌ. Õ1RUNBIO BIOTECH5.68
ÒÅÑÒ BEE SURE-S ÍÀ ÁÅÐÅÌ. (ÁÈ-ØÓÐ-Ñ) Õ1ÔÀÊÒÎÐ-ÌÅÄ5.51
ÒÅÑÒ EVA ÍÀ ÁÅÐÅÌ. Õ1MILTOM INC5.61
ÒÅÒÐÀËÃÈÍ ÒÀÁË. Õ10NOVENTIS/ÔÀÐÌÂÈËÀÐ57.93
ÒÅÒÐÀÖÈÊËÈÍ È ÍÈÑÒÀÒÈÍ ÒÀÁË. 100000 ÅÄ Õ10ÁÈÎÑÈÍÒÅÇ9.48
ÒÅÒÐÀÖÈÊËÈÍ ÌÀÇÜ 3 % ÒÓÁÀ 15 Ã. Õ1ÁÈÎÑÈÍÒÅÇ11.93
ÒÅÒÐÀÖÈÊËÈÍ ÌÀÇÜ ÃËÀÇÍ. 1 % 10 Ã. Õ1ÒÀÒÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ32.03
ÒÅÒÐÀÖÈÊËÈÍ ÌÀÇÜ ÃËÀÇÍ. 1 % 3 Ã. Õ1ÒÀÒÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ25.16
ÒÅÒÓÐÀÌ ÒÀÁË. 150 ÌÃ Õ30ÔÀÐÌÑÒÀÍÄÀÐÒ ËÅÊÑÐÅÄÑÒÂÀ11.67
ÒÅÒÓÐÀÌ ÒÀÁË. 150 ÌÃ Õ50ÒÀÒÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ14.27
ÒÈÀÏÐÈÄ ÒÀÁË. 100 ÌÃ Õ30ÎÐÃÀÍÈÊÀ145.19
ÒÈÀÏÐÈÄÀË Ð-Ð Â/Â È Â/Ì ÂÂÅÄ. 100 ÌÃ 2 ÌË. Õ12SANOFI333
ÒÈÇÈÍ 0.05 % ÔË. 10 ÌË. Õ1HEINRICH MACK80.87
ÒÈÇÈÍ 0.1 % ÔË. 10 ÌË. Õ1HEINRICH MACK86.38
ÒÈÇÈÍ ÊÑÈËÎ ÑÏÐÅÉ Ä/ÍÎÑÀ 0.05 % ÔË. 10 ÌË. (140 ÄÎPFIZER/MCNEIL MANUFACTURI101.59
ÒÈÇÈÍ ÊÑÈËÎ ÑÏÐÅÉ Ä/ÍÎÑÀ 0.1 % ÔË. 10 ÌË. (70 ÄÎÇ)PFIZER/MCNEIL MANUFACTURI100.77
ÒÈÌÀËÈÍ ËÈÎÔ. 10 ÌÃ ÔË. Õ10ÑÀÌÑÎÍ-ÌÅÄ125.33
ÒÈÌÎËÎË ÊÀÏËÈ ÃËÀÇ. 0.25 % ÔË./ÊÀÏ. ÏËÀÑÒ. 5 ÌË. ÕROMPHARM25.9
ÒÈÌÎËÎË ÊÀÏËÈ ÃËÀÇ. 0.5 % ÔË./ÊÀÏ. ÏËÀÑÒ. 5 ÌË. Õ1ROMPHARM29.52
ÒÈÎÊÒÀÖÈÄ ÁÂ ÒÀÁË. Ï/Î 600 ÌÃ Õ30VIATRIS GMBH&CO.KG/AWD1362.95
ÒÈÐÅÎÊÎÌÁ ÒÀÁË. Õ40BERLIN-CHEMIE AG/MENARINI135.65
ÒÈÐÅÎÒÎÌ ÒÀÁË. Õ60BERLIN-CHEMIE AG/MENARINI164.59
ÒÎÁÐÎÏÒ ÊÀÏËÈ ÃËÀÇ. 0.3 % 5 ÌË. Õ1ROMPHARM122.99
ÒÎËÎÊÍßÍÊÀ ËÈÑÒÜß Â ÏÀ×ÊÅ 50 Ã. Õ1ÊÐÀÑÍÎÃÎÐÑÊ ËÅÊ ÑÐ-ÂÀ25.96
ÒÎËÎÊÍßÍÊÀ ËÈÑÒÜß Ô/Ï. 1.5 Ã. Õ20ÊÐÀÑÍÎÃÎÐÑÊ ËÅÊ ÑÐ-ÂÀ27.95
ÒÎÍÇÈËÃÎÍ Í ÄÐÀÆÅ Õ50BIONORICA ARZNEIMITTEL200.47
ÒÎÍÇÈËÃÎÍ Í ÊÀÏËÈ 100 ÌË. Õ1BIONORICA ARZNEIMITTEL279.79
ÒÎÒÅÌÀ Ð-Ð ÀÌÏ. 10 ÌË. Õ20INNOTECH INT/INNOTHERA CH180.61
ÒÐÀÂÈÑÈË /ÀÏÅËÜÑÈÍ/ ÒÀÁË. Õ16PLETHICO PHARMACEUTICALS39.22
ÒÐÀÂÈÑÈË /ËÈÌÎÍ/ ÒÀÁË. Õ16PLETHICO PHARMACEUTICALS37.94
ÒÐÀÂÈÑÈË /ÌÅÄ/ ÒÀÁË. Õ16PLETHICO PHARMACEUTICALS38.33
ÒÐÀÂÈÑÈË /ÌßÒÀ/ ÒÀÁË. Õ16PLETHICO PHARMACEUTICALS38.46
ÒÐÀÂÈÑÈË ÑÈÐÎÏ 100 ÌË. Õ1PLETHICO PHARMACEUTICALS58.26
ÒÐÅÍÒÀË ÀÌÏ. 5 ÌË. Õ5AVENTIS136.25
ÒÐÅÍÒÀË ÒÀÁË. Ï/Î 400 ÌÃ Õ20AVENTIS187.76
ÒÐÅÍÒÀË ÒÀÁË. ÏÎÊÐ. ÊÈØ-ÐÀÑÒÂ. ÎÁÎË. 100 ÌÃ Õ60AVENTIS140.03
ÒÐÈ-ÐÅÃÎË ÒÀÁË. Õ28GEDEON RICHTER125.65
ÒÐÈ-ÐÅÃÎË ÒÀÁË. Õ84GEDEON RICHTER327.77
ÒÐÈÀÊÎÐÒ ÌÀÇÜ 0.1 % 10 Ã. Õ1ÀÊÐÈÕÈÍ27.18
ÒÐÈÀÌÏÓÐ ÊÎÌÏÎÇÈÒÓÌ ÒÀÁË. (12.5ÌÃ/25ÌÃ) Õ50AWD182.34
ÒÐÈÃÀÍ-Ä ÒÀÁË. 500 ÌÃ Õ100CADILA PHARMACEUTICALS139.36
ÒÐÈÃÀÍ-Ä ÒÀÁË. Õ20CADILA PHARMACEUTICALS36.17
ÒÐÈÄÅÐÌ ÊÐÅÌ 15 Ã. Õ1SCHERING-PLOUGH350.69
ÒÐÈÄÅÐÌ ÌÀÇÜ 15 Ã. Õ1SCHERING-PLOUGH368.37
ÒÐÈÌÅÒÀÇÈÄÈÍ ÒÀÁË. Ï/Î 20 ÌÃ Õ30ÊÀÍÎÍÔÀÐÌÀ ÏÐÎÄÀÊØÍ77.57
ÒÐÈÌÅÒÀÇÈÄÈÍ ÒÀÁË. Ï/Î 20 ÌÃ Õ60ÊÀÍÎÍÔÀÐÌÀ ÏÐÎÄÀÊØÍ105.67
ÒÐÈÎÌÁÐÀÑÒ Ð-Ð Ä/ÈÍÚÅÊ. 76 % ÀÌÏ. 20 ÌË. (ÓÐÎÃÐÀÔÈÔÀÐÌÀÊ451.93
ÒÐÈÏÑÈÍ ÔË. 0.01 Ã. Õ10ÑÀÌÑÎÍ-ÌÅÄ305.7
ÒÐÈÐÅÇÈÄ Ê ÒÀÁË. 200 ÌÃ Õ40PLIVA - ÑÎÒÅÊÑ63.21
ÒÐÈÑÎËÜ Ð-Ð ÔË. 200 ÌË. Õ1ÝÑÊÎÌ18.97
ÒÐÈÑÎËÜ Ð-Ð ÔË. 400 ÌË. Õ1ÝÑÊÎÌ21.46
ÒÐÈÔÒÀÇÈÍ Ð-Ð 0.2 % ÀÌÏ. 1 ÌË. Õ10ÄÀËÜÕÈÌÔÀÐÌ31.06
ÒÐÈÔÒÀÇÈÍ ÒÀÁË. Õ50ÇÄÎÐÎÂÜÅ ÇÀÎ ÔÀÐÌÀÖÅÂÒÈ×Å13.92
ÒÐÈÕÎÏÎË ÒÀÁË. 250 ÌÃ Õ20POLPHARMA68.76
ÒÐÎÊÑÅÂÀÇÈÍ ÃÅËÜ 2 % 40 Ã. Õ1BALKANPHARMA63.58
ÒÐÎÊÑÅÐÓÒÈÍ ÃÅËÜ 2 % ÒÓÁÀ 40 Ã. Õ1ÂÅÒ ÏÐÎÌ ÀÄ27.49
ÒÐÎÌÁËÅÑÑ ÃÅËÜ ÒÓÁÀ 30 Ã. Õ1ÍÈÆÔÀÐÌ ÎÀÎ83.34
ÒÐÎÌÁÎ ÀÑÑ ÒÀÁË. Ï/Î 100 ÌÃ Õ30LANNACHER HEILMITTEL GMBH83.5
ÒÐÎÌÁÎ ÀÑÑ ÒÀÁË. Ï/Î 50 ÌÃ Õ30LANNACHER HEILMITTEL GMBH74.47
ÒÐÎÏÈÊÀÌÈÄ ÊÀÏËÈ ÃËÀÇ. 0.5 % ÔË./ÊÀÏ. 10 ÌË. Õ1ROMPHARM49.46
ÒÐÎÏÈÊÀÌÈÄ ÊÀÏËÈ ÃËÀÇ. 1 % ÔË./ÊÀÏ. 10 ÌË. Õ1ROMPHARM91.02
ÒÓÑÑÀÌÀÃ ÊÀÏËÈ ÔË. 20 Ã. Õ1MERCKLE GMBH53.42
ÒÓÑÑÀÌÀÃ ÊÀÏËÈ ÔË. 50 Ã. Õ1MERCKLE GMBH95.57
ÒÓÑÑÀÌÀÃ ÑÈÐÎÏ ÔË. 175 ÌË. (ÁÅÇ ÑÀÕÀÐÀ) Õ1MERCKLE GMBH107.01
ÒÓÑÑÈÍ ÏËÞÑ ÑÈÐÎÏ ÔË. 118 ÌË. Õ1SAGMEL INC103.2
ÒÓÑÑÈÍ ÑÈÐÎÏ ÔË. 118 ÌË. Õ1SAGMEL INC79.66
ÒÛÊÂÅÎË ÊÀÏÑ. 450 ÌÃ Õ50ÅÂÐÎÏÀ-ÁÈÎÔÀÐÌ81.53
ÒÛÊÂÅÎË ÔË. 100 ÌË. Õ1ÅÂÐÎÏÀ-ÁÈÎÔÀÐÌ159.89




2001-2011 http://www.med.sgg.ru - öåíû íà ëåêàðñòâà, ìåäòåõíèêó, âñå äëÿ ñòîìàòîëîãèè, õèðóðãè÷åñêèé è äðóãîé ìåäèöèíñêèé èíñòðóìåíò è òåõíèêà, ôàðìàöåâòè÷åñêèå ïðåïàðàòû è ñóáñòàíöèè îò ïðîèçâîäèòåëåé è îïòîâûõ ïðîäàâöîâ â Ìîñêâå, Ñàíêò-Ïåòåðáóðãå è äðóãèõ ðåãèîíàõ.



Rambler's Top100 Rambler's Top100 Ðåéòèíã@Mail.ru